New Jersey Substance Abuse Monitoring Systems (NJ-SAMS)
Data Security

       Substance abuse treatment providers in New Jersey and other states must comply with federal law regarding the confidentiality and security of health information. All substance abuse treatment programs receiving federal funds directly or indirectly are subject to 42 CFR Part 2 and most are subject to the HIPAA Privacy Rule.

      The implementation of HIPAA will require all of us who use and transmit health information to review our policies and procedures to insure compliance with existing and new regulations. For those of us who work with substance abuse patients, the regulations on the use of health data introduced by HIPAA are not significantly more restrictive than the requirements of 42 CFR Part 2. Protecting patient confidentiality is and has been a high priority, as well as the law for substance abuse providers. HIPAA does, however, directly address the privacy issues involved in "electronic transmissions" which are not explicitly covered in 42 CFR Part 2.

      NJ-SAMS, the web based treatment reporting system being implemented by the Division of Addiction Services, has been developed with a strong emphasis on the security of transactions.As required by HIPAA, two levels of login and password protect all access to the web forms and data is encrypted and sent via secure web pages between the treatment provider's computer and the NJ-SAMS web server. Information transmitted from the web server to the local site is encrypted as well. The NJSAMS servers are protected by a firewall that monitors every transaction and protects the database from hackers, viruses, and other illegal access. The MS SQL database provides another level of security to limit access to records and fields to only those users with defined rights to view data. NJ-SAMS provides the ability to delete personal identifiers for those patients who do not permit the transmission of these identifiers to NJ-SAMS. No data is transferred to another treatment program without an indicator in NJ-SAMS that the provider has obtained the signed consent of the patient.

      We hope that this information helps you understand the changes introduced by HIPAA relating to patient records generated in the substance abuse treatment process and the security measures implemented in NJ-SAMS.

                 For more information, please contact: Charles Crowley 609-292-8930 or Email: charles.crowley@dhs.state.nj.us